Business Description
Zivo Bioscience Inc
NAICS : 325412
SIC : 2834
ISIN : US98978N3098
Description
Zivo Bioscience Inc is a research and development company operating in both the biotech and agtech sectors, with an intellectual property portfolio comprised of proprietary algal and bacterial strains, biologically active molecules and complexes, production techniques, cultivation techniques, and patented or patent-pending inventions for applications in human and animal health. The company's candidates are; Bovine Mastitis, Canine Joint Health, Human Immune Modulation, Companion Animal Food Ingredient, NDI (New Dietary Ingredient, and Skin Health.
Financial Strength
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Equity-to-Asset | -3.99 | |||||
| Debt-to-Equity | -0.25 | |||||
| Debt-to-EBITDA | -0.05 | |||||
| Piotroski F-Score | 4/9 | |||||
| Altman Z-Score | -388.26 | |||||
| Beneish M-Score | -56.07 | |||||
| WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | -9.6 | |||||
| 3-Year EBITDA Growth Rate | 24.4 | |||||
| 3-Year EPS without NRI Growth Rate | 24.2 | |||||
| 3-Year FCF Growth Rate | -4.5 | |||||
| 3-Year Book Growth Rate | 58.7 |
Momentum Rank
3/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 3.59 | |||||
| 9-Day RSI | 5.92 | |||||
| 14-Day RSI | 6.79 | |||||
| 6-1 Month Momentum % | -97.14 | |||||
| 12-1 Month Momentum % | -96.7 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 0.17 | |||||
| Quick Ratio | 0.17 | |||||
| Days Sales Outstanding | 22.31 | |||||
| Days Payable | 9682.79 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -40.4 | |||||
| Shareholder Yield % | -2.45 |
Profitability Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 35 | |||||
| Operating Margin % | -21625 | |||||
| Net Margin % | -22080 | |||||
| FCF Margin % | -8447.27 | |||||
| ROA % | -1391.6 | |||||
| ROIC % | -612.14 | |||||
| 3-Year ROIIC % | -22.31 | |||||
| ROC (Joel Greenblatt) % | -13321.36 | |||||
| Years of Profitability over Past 10-Year | 1 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PS Ratio | 750 | |||||
| EV-to-EBIT | -5.36 | |||||
| EV-to-EBITDA | -5.36 | |||||
| EV-to-Revenue | 1158.52 | |||||
| EV-to-FCF | -13.88 | |||||
| Earnings Yield (Greenblatt) % | -18.66 | |||||
| FCF Yield % | -7.27 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Zivo Bioscience Inc Executives
DetailsGF Value
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil €) | 0.055 | ||
| EPS (TTM) (€) | -0.984 | ||
| Beta | 0 | ||
| Volatility % | 105.91 | ||
| 14-Day RSI | 6.79 | ||
| 14-Day ATR (€) | 0.023872 | ||
| 20-Day SMA (€) | 0.443 | ||
| 12-1 Month Momentum % | -96.7 | ||
| 52-Week Range (€) | 0.418 - 19.319999 | ||
| Shares Outstanding (Mil) | 1.82 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 4 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Zivo Bioscience Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Zivo Bioscience Inc Stock Events
| Event | Date | Price(€) | ||
|---|---|---|---|---|
| No Event Data | ||||
Zivo Bioscience Inc Frequently Asked Questions
What is Zivo Bioscience Inc(STU:9R80)'s stock price today?
The current price of STU:9R80 is €0.44. The 52 week high of STU:9R80 is €19.32 and 52 week low is €0.42.
When is next earnings date of Zivo Bioscience Inc(STU:9R80)?
The next earnings date of Zivo Bioscience Inc(STU:9R80) is 2024-11-13 Est..
Does Zivo Bioscience Inc(STU:9R80) pay dividends? If so, how much?
Zivo Bioscience Inc(STU:9R80) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers